Liang Peng, Doctor
Third Affiliated Hospital, Sun Yat-Sen University
17
17
0
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (17)
Showing 10 of 17 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Stephen A. Harrison, MD
Brooke Army Medical Center
Shared therapeutic areas:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Dale L. Phelps, MD
University of Rochester
Shared therapeutic areas:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Neil N. Finer, MD
University of California, San Diego
Shared therapeutic areas:
Edward F. Donovan, MD
Children's Hospital Medical Center, Cincinnati
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (17)
Showing 17 of 17 trials
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection
Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients
RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF
All 17 trials loaded